The enzyme Wip-1 is a serine/threonine phosphatase with oncogenic properties. Over expression of Wip-1 has been observed in several cancers, including breast cancer, neuroblastoma, and ovarian clear cell adenocarcinoma. The phosphatase Wip-1 indirectly suppresses the activity of protein p53, a protein that functions as a tumor suppressor and is frequently described as the �guardian of the genome.�Targeting Wip-1 with small molecule inhibitors represents a novel approach to restore tumor suppressor function and subsequent cancer cell arrest/apoptosis. We recently reported the design, solid-phase synthesis, and inhibition data of a series of selective Wip-1 inhibitors bearing a penta-substituted pyrrole core. To further establish the structure-activity relationships (SARs) and to identify potent inhibitors for crystal structure studies, a synthetic route amenable for large-scale solution phase synthesis was designed. The synthesis is based on Knoevenagel-Stetter-Paal-Knorr sequence, and features stepwise incorporation of substituents. The inhibition data against Wip-1 phosphatase will be described along with an analysis of the selectivity of the molecules for Wip-1 over other phosphatases.

Synthesis of pyrrole derivatives for selective inhibition of Wip-1 phosphatase

244th National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.